


Crescenta Biosciences Email Formats
Biotechnology Research • Elizabeth, New Jersey, United States • 1-10 Employees
Crescenta Biosciences Email Formats
Crescenta Biosciences uses 1 email format. The most common is {first initial} (e.g., j@crescentabio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@crescentabio.com | 100% |
Key Contact at Crescenta Biosciences
Emre Koyuncu
Founder & CEO
Company overview
| Headquarters | 1075 Morris Ave, Union, New Jersey 07083, US |
| Phone number | +16096080568 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2015 |
| Employees | 1-10 |
| Socials |
About Crescenta Biosciences
Crescenta Biosciences Inc. is a small molecule drug discovery company focused on developing novel therapeutic approaches for diseases related to fatty acid metabolism. Crescenta’s discovery platform is based on a new concept that allows for the manipulation of biological functions associated with “fatty acid interacting proteins” in such a way to correct metabolic imbalance, thus providing broad therapeutic opportunities. By applying this unique platform, the company has assembled a portfolio of first-in-class drug candidates for the treatment of diseases with major unmet medical needs, particularly those related to metabolism and aging. Crescenta’s goal is to advance its pipeline into clinical development and commercialization.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Crescenta Biosciences has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Crescenta Biosciences has never raised funding before.
Crescenta Biosciences Tech Stack
Discover the technologies and tools that power Crescenta Biosciences's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
PaaS
Blogs
Miscellaneous
Programming languages
Miscellaneous
Security
JavaScript frameworks
Blogs
IaaS
Frequently asked questions
4.8
40,000 users



